First Bight Ventures is the first early stage fund that is dedicated to synthetic biology start-ups. The firm sees the potential of syn-bio across broad range of verticals that could truly transform the world for a sustainable future.

These focus sectors are (but not limited to) energy, chemical, agriculture, medicine, heavy industries and consumer goods.

First Bight Venture invests in early and seed stage startups with a ticket size between $1 million and $5 million.

Its portfolio companies includes Algenesis, Visolis, Persephone, and R2dio.